MedTrace Logo

MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads

NCT05199870 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2026-03-19

No results posted yet for this study

Summary

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the RingLoc Bipolar Acetabular Cup and the Endo II Femoral Head when used for hip hemiarthroplasty (implants and instrumentation).

Conditions

  • Hip Arthritis
  • Hip Disease
  • Hip Fractures
  • Hip Injuries
  • Hip Pain Chronic

Interventions

DEVICE

RingLoc Bipolar Acetabular Cup

Patients that have been implanted with a RingLoc Bipolar acetabular cup.

DEVICE

Endo II Femoral Head

Subjects that have been implanted with an Endo II Femoral Head

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Lynsey Boyle · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2027-03-31
Completion
2027-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05199870 on ClinicalTrials.gov